June 15, 2022
2 min watch
Save
VIDEO: Wearable migraine treatment Nerivio shows ‘persistent efficacy’ in patients
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
DENVER — Nerivio, a noninvasive digital therapeutic device, provided migraine pain relief within 2 hours in 67% of adults and 71% of adolescents, Alon Ironi said at the American Headache Society’s annual scientific meeting.
“We have shown persistent efficacy over a long time, and we have demonstrated real-world efficacy in thousands of patients,” Ironi, CEO and co-founder of device manufacturer Theranica, said. “We’re moving forward with our clinical development, and we’re working on expanding the review to the preventive treatment of migraine. This is something that is in development right now.”